Loading insider details...
Beta
Latest Form 4 (Sep 10, 2026): Grant/Award of 48,445 KRSA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 10, 2026 | Korsana Biosciences, Inc. (KRSA) | Grant/Award | 48,445 | n/a |
| Jun 12, 2026 | Apogee Therapeutics, Inc. (APGE) | Grant/Award | 7,657 | n/a |
| Mar 27, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Sale | 174,485 | $2.96M |
| Oct 15, 2025 | Apogee Therapeutics, Inc. (APGE) | Purchase | 365,853 | $15.00M |
| Jun 21, 2025 | Apogee Therapeutics, Inc. (APGE) | Grant/Award | 14,461 | n/a |
| Apr 11, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Purchase | 25,000 | $235.5K |
| Feb 27, 2025 | Oruka Therapeutics, Inc. (ORKA) | Purchase | 574 | $6.3K |
| Feb 15, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Purchase | 100,000 | $923.0K |
| Feb 12, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Purchase | 73,649 | $684.2K |
| Feb 4, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Purchase | 43,707 | $382.9K |